Target intelligence / Profile preview

Glutathione S-transferase P 1 (GSTP1) (GSTP1)

Target
GSTP1
Molecular classification
Enzyme, Glutathione S-transferase family, Carotenoid-binding protein
01

Overview

Glutathione S-transferase P 1 (GSTP1) is a multifunctional enzyme that serves as the primary zeaxanthin-binding protein in the human macula (Bhosale et al., 2004). Located within the retinal cell membranes and cytoplasm of the Henle fiber layer, GSTP1 specifically binds and stabilizes zeaxanthin, a xanthophyll carotenoid essential for ocular health (Li et al., 2011). This interaction is crucial for maintaining macular pigment optical density, which protects the retina by filtering high-energy blue light and providing potent antioxidant defense against photo-oxidative damage (Bernstein et al., 2016). Dysregulation or low levels of GSTP1-bound zeaxanthin are strongly associated with the development and progression of age-related macular degeneration (AMD) (UniProt P09211). Beyond its role in the eye, GSTP1 is a key detoxification enzyme involved in conjugating glutathione to electrophilic compounds, and its expression levels are often altered in various cancers, influencing drug resistance and susceptibility to environmental toxins (PubMed: 15159469). It also acts as a regulator of the JNK signaling pathway, thereby influencing apoptosis and cellular stress responses (UniProt P09211).

Other names
Zeaxanthin-binding proteinZBPGSTP1-1Glutathione S-transferase pi 1GST3Glutathione S-transferase P
02

Mechanism of action

Drugs and nutrients interact with GSTP1 either as ligands that are sequestered and stabilized (e.g., zeaxanthin for retinal protection) or as inhibitors and prodrug substrates that modulate its enzymatic and signaling activities (e.g., ezatiostat for hematological conditions or canfosfamide for cancer treatment).

03

Biological functions

Carotenoid bindingAntioxidant activityDetoxificationBlue light filtrationApoptosis regulation
04

Disease associations

Age-related macular degenerationProstate cancerBreast cancerAsthmaMyelodysplastic syndrome
05

Safety considerations

Genetic variants like the Val105 allele may reduce protective antioxidant capacityGSTP1 overexpression is a major driver of multi-drug resistance in chemotherapyInhibition may lead to increased cellular damage from electrophilic metabolites
06

Interacting drugs

Zeaxanthin

4 more in the full profile.

07

Biomarkers

GSTP1 Ile105Val polymorphism statusMacular pigment optical density (MPOD)GSTP1 promoter hypermethylation

Beyond the preview

Go deeper on Glutathione S-transferase P 1 (GSTP1) (GSTP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutathione S-transferase P 1 (GSTP1) (GSTP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call